Bobo-Dioulasso, Burkina Faso
Bobo-Dioulasso, Burkina Faso

Time filter

Source Type

Bamba S.,Bobo-Dioulasso Polytechnic University | Bamba S.,Center Hospitalier University Sanou Souro | Lortholary O.,Institute Pasteur Paris | Lortholary O.,French National Center for Scientific Research | And 8 more authors.
AIDS | Year: 2012

Cryptococcosis remains a major opportunistic infection in AIDS in sub-Saharan Africa, but few data exist from its western part. We report data from Bobo Dioulasso University Hospital, Bobo-Dioulasso, Burkina Faso, with a steady decline from 14 to two cases per year from 2002 to 2010 which contrasts with the increase (from 147 to 3940) of patients on antiretroviral therapy (ART). Better ART availability decreases the incidence of cryptococcosis in Burkina Faso. © 2012 Wolters Kluwer Health | Lippincott Williams and Wilkins.


Bamba S.,Center hospitalier University Sanou Souro | Bamba S.,Bobo-Dioulasso Polytechnic University | Barro-Traore F.,University of Ouagadougou | Sawadogo E.,Center hospitalier University Sanou Souro | And 2 more authors.
Journal de Mycologie Medicale | Year: 2012

Aims of the study: To study the prevalence of neuromeningeal cryptococcosis since the availability of antiretroviral drugs and to determine the epidemiological profiles, clinical and biological treatment of neuromeningeal cryptococcosis cases diagnosed in the service of parasitology and mycology of university hospital center of Bobo-Dioulasso from 2002 to 2010. Patients, material and methods: We included all patients diagnosed with neuromeningeal cryptococcosis for which the presence of the fungi was observed on microscopic examination of cerebrospinal fluid after staining with Indian ink. Data were collected from the registers of the clinical service and from the laboratory of the university hospital center of Bobo Dioulasso. Results: The prevalence of neuromeningeal cryptococcosis was 1.8% (61/5129). A decrease in the prevalence was observed from 2002 to 2010 (3.1%, to 0.2%). This decrease occurred even though the number of patients treated with antiretroviral drugs increase. Headaches were the predominant clinical signs (81.9%). The CD4 median count was 56/mm3. All patients were successfully treated with fluconazole in relay to amphotericin B intravenous. Lethality rate is 27.8%. Conclusion: The overall prevalence of 1.8% of neuromeningeal cryptococcosis observed in this study was lower than that in previous studies in the same laboratory in 2001. The arrival of antiretroviral drugs could have contributed to the decline in the prevalence of neuromeningeal cryptococcosis in this study. © 2011 Elsevier Masson SAS.

Loading Center Hospitalier University Sanou Souro collaborators
Loading Center Hospitalier University Sanou Souro collaborators